Detailed explanation of the standard dosage and administration time of furmonertinib

Furmonertinib (Furmonertinib) is an oral third-generation EGFRtyrosine kinase inhibitor (TKI), mainly used to treat EGFR Patients with T790Mmutation-positive advanced non-small cell lung cancer (NSCLC). Its main mechanism of action is to achieve anti-tumor effects by selectively inhibiting the mutant EGFR signaling pathway and blocking tumor cell proliferation and survival. Fumetinib is an oral tablet that is convenient for patients to take at home for a long time and is suitable for continuous treatment.

In terms of standard usage and dosage, the recommended starting dose of fumetinib is once daily, 80 mg each time. Tablets should be swallowed whole and not broken or chewed to ensure sustained release and stability of the drug. For some patients who tolerate the drug well and require individualized adjustment, clinicians can increase or decrease the dose appropriately based on blood drug concentration or adverse reactions, but the overall dose range is usually between 40 mg and 160 mg to balance efficacy and safety.

In terms of medication time, fumetinib does not have strict meal requirements and can be taken before, after, or on an empty stomach. However, it is recommended to take the medication at a fixed time every day to maintain stable blood concentration and improve efficacy. If the patient forgets to take the medicine, he should take it as soon as possible. However, if the next dose is close, the missed dose should be skipped to avoid overdose caused by repeated taking.

During the period of using fumetinib, patients should be followed up regularly and have hematology and liver and kidney function monitoring performed to detect potential adverse reactions in a timely manner, such as rash, diarrhea, abnormal blood indicators, etc. At the same time, it is necessary to avoid combined use with strong CYP3A4 inhibitors or inducers to prevent drug metabolism from being affected. Standard usage and dosage and scientific medication schedule are the keys to ensuring the maximum efficacy and safety of fumetinib.

Reference link:https://www.drugs.com